no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acute GVHD: New approaches to clinical trial monitoring
|
Spyrou, Nikolaos |
|
|
35 |
4 |
p. |
article |
2 |
Consolidation chemotherapy in AML: Are we playing with a full deck of cards?
|
Stone, Richard M. |
|
|
35 |
4 |
p. |
article |
3 |
Editorial Board / Aims & Scope
|
|
|
|
35 |
4 |
p. |
article |
4 |
How can we design a better care model to address the acute distress of an acute leukemia diagnosis? Care models to address the acute distress of an acute leukemia diagnosis
|
El-Jawahri, Areej |
|
|
35 |
4 |
p. |
article |
5 |
How can we improve response assessments in MDS? Strategies to improve response assessment in MDS treatment paradigms
|
Bejar, Rafael |
|
|
35 |
4 |
p. |
article |
6 |
How can we incorporate molecular data into the IPSS?
|
Bejar, Rafael |
|
|
35 |
4 |
p. |
article |
7 |
How can we intervene to mitigate post-transplantation relapse in AML? Strategies to mitigate post-transplantation relapse in AML
|
Gutman, Jonathan A. |
|
|
35 |
4 |
p. |
article |
8 |
Improving clinical trials in higher-risk myelodysplastic syndromes
|
Sekeres, Mikkael A. |
|
|
35 |
4 |
p. |
article |
9 |
Measurable residual disease in acute lymphoblastic leukemia: How low is low enough?
|
Logan, Aaron C. |
|
|
35 |
4 |
p. |
article |
10 |
Recent progress in acute leukemia and myelodysplasia
|
Carraway, Hetty E. |
|
|
35 |
4 |
p. |
article |
11 |
Should all CAR-T therapy for acute lymphoblastic leukemia Be consolidated with allogeneic stem cell transplant?
|
Marinos, Alejandro |
|
|
35 |
4 |
p. |
article |
12 |
What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALL
|
Gore, Lia |
|
|
35 |
4 |
p. |
article |
13 |
When will chemotherapy be replaced in upfront induction therapy for adult acute lymphoblastic leukemia (ALL)?
|
Advani, Anjali |
|
|
35 |
4 |
p. |
article |